Search results for: 'medicine ad regenerative'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent developments for intelligent drug discovery solutions, precision oncology and novel biologics. The TOE also comprises innovations across stem cell therapies and radiotherapies.The Life Science, Health & Wellness TOE will feature d...

Precision medicine is transitioning toward wider acceptance, due to mounting payer pressures and regulatory changes that are shifting pharma businesses from prescriptive to more predictive and personalized models. Emergence of value-based reimbursement models and healthcare consumerism trends are helping move the treatment model from ‘one-size-fits...

Server-side ad insertion has normally been about tackling the problems of ad blocking and device fragmentation. But the industry is now seeing platform shifts that change the sweet spot of ad stitching towards live and catch-up TV. Client-side ad SDKs have grown in sophistication, the platforms they run have become more capable and the transition t...

Several European countries, including Germany, the United Kingdom, and Denmark, are at the forefront of leveraging the potential of biogas produced through the anaerobic digestion (AD) of energy crops, agricultural waste, organic waste, and sewage sludge. Subsidies and incentives are the key growth drivers. As part of its Net Zero by 2050 Strategy,...

09 May 2019  |  North America  |  Market Outlook

Global Autonomous Driving (AD) Industry Outlook, 2019

1 in 4 Cars Sold (18 Million) Globally is Expected to be Automated (L3 and Above) by 2030, with L4 Driving the Growth of Ownership

Infographics

×

Key Issues Addressed

The autonomous driving industry is evolving at a rapid pace on various fronts such as advancements in technology as well as emergence of new business models. Traditionally, most major OEMs and Tier I suppliers have strived to explore the benefits of developing applications focused on the convergence of the three technology pillars: Connected, Auton...

The geospatial value-added services market is seeing an influx of new participants owing to cheaper satellite data products and services and enabling information and communication technologies. Established incumbents have to compete with not only these participants but also new customer groups arising from the evolution of new use cases. The marke...

The concept of companion diagnostics (CDx) was developed when researchers realized that even potent drugs only had an efficacy between 25% and 60%, the lowest being in oncology. Therefore, a clinical pharmacogenetic assay became important to distinguish patients more likely to respond to a drug or at a lesser risk of associated adverse pathophysiol...

The medical imaging and informatics industry is evolving, with vendors launching new products and solutions every other day. As the reimbursement environment transitions from fee-for-service to value-based payment, vendors business models and value propositions are changing. New evidence on the use of specific imaging techniques is influencing chan...